Global Health Investment Corporation
Impact investorNew York · Seed–Series B · 4 people tracked
Also known as GHIC ADVISORS, LLC
Find your way into Global Health Investment Corporation
2,365 people in our graph share verified history with the Global Health Investment Corporation team — schools, employers, funds. One of them is your warm intro.
Investment thesis
GHIC invests to catalyze technologies that improve human health worldwide, focusing on strengthening global health security and addressing urgent challenges such as infectious disease and maternal and child health. Its namesake $108M social impact fund (GHIF) backed twelve companies developing clinical diagnostics, devices, vaccines, and therapeutics targeting infectious diseases that disproportionately affect low- and middle-income countries, including HIV/AIDS, malaria, tuberculosis, and cholera. In partnership with BARDA at the U.S. Department of Health and Human Services, GHIC uses venture investments to support technologies that respond to or prevent public health emergencies such as pandemics and other global health security threats.
Source: firm website, verified Sep 15, 2026.
Team · 4 people
from the firm's website & curated & public directories
What they invest in
from 3 of 5 portfolio companiesBiotech ×3Advanced Manufacturing ×2Circular Economy ×1Cleantech ×1Healthtech ×1New Materials ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12 dated
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina D. Smolke(Executive Officer, Director)inChristina Smolke(Co-Founder & CEO)inKristy Hawkins(Co-Founder & CSO)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
Co-investorsAmerica's Frontier FundCivilization Ventures Management, LlcLam CapitalSherpalo Ventures
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesAthosCivilization Ventures Management, LlcIn-Q-TelSherpalo VenturesViking Global Investors
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Micron BiomedicalUnivercells’s websiteVaxess Technologies, Inc.
Portfolio news
latest coverage across their companiesVaxess Technologies, Inc. · finsmes.com · Mar 26, 2026
Antheia, Inc. · fiercepharma.com · Jan 28, 2026
Biosynthetic · biopharmatrend.com · Jun 4, 2025
Frequently asked questions
- How many investments has Global Health Investment Corporation made?
- Global Health Investment Corporation has 5 tracked investments, including 2 dated in the last 24 months.
- What stage does Global Health Investment Corporation invest at?
- Global Health Investment Corporation invests at the Seed, Series A, Series B stages.
- What sectors does Global Health Investment Corporation focus on?
- Global Health Investment Corporation focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Global Health Investment Corporation located?
- Global Health Investment Corporation is headquartered in New York, US.
Co-investors · 3
Entrepreneur First (EF) is a talent investor that helps individuals build and launch startups, providing support such as US visa guidance, office space, fundraising preparation, and investor introductions culminating in a San Francisco Demo Day.
Adjuvant Capital is a venture capital firm that finances life science technologies addressing high-burden public health challenges, aiming to deliver both social and financial returns.
Global Health Investment Corporation is a nonprofit organization that invests in life sciences and healthcare technology companies to develop and commercialize products addressing global health challenges, particularly infectious diseases and maternal and child health in low- and middle-income countries.
Firms observed investing alongside Global Health Investment Corporation, from public investor directories. Shared companies are the overlap with Global Health Investment Corporation's recorded portfolio.
Similar investors
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Cancer Fund is an early-stage oncology venture capital and venture-giving organization that funds diagnostics, therapeutics, and other cancer-targeting innovations, offering both charitable donation and accredited-investor pathways.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.